---
document_datetime: 2023-09-21 18:23:35
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/evarrest-epar-all-authorised-presentations_en.pdf
document_name: evarrest-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9448481
conversion_datetime: 2025-12-21 18:59:05.378123
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength     | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Content (concentration)            |   Pack size |
|------------------|-------------------|--------------|-----------------------|---------------------------|-----------------------|------------------------------------|-------------|
| EU/1/13/868/001  | EVARREST          | 8.1 mg 40 IU | Sealant matrix        | Epilesional use           | Sachet                | sealant matrix (10.2 cm x 10.2 cm) |           1 |
| EU/1/13/868/002  | EVARREST          | 8.1 mg 40 IU | Sealant matrix        | Epilesional use           | Sachet                | sealant matrix (5.1 cm x 10.2 cm)  |           2 |

<!-- image -->